Axol Bioscience
We are happy to introduce Axol Bioscience!
Axol Bioscience believes that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. They use human iPSCs to achieve this and have been doing so for over a decade.
They take cells from patient and healthy donors and, using their leading iPSC technology, work with researchers to build physiologically relevant in vitro models. They have a special focus on neurodegenerative diseases, such as Alzheimer’s Disease, as well as cardiotoxicity to promote drug safety.
axoCells™
With over a decade of experience, Axol has developed the manufacturing capabilities to produce high-quality, functional iPSC-derived cells with excellent consistency. Your research can benefit from their quality-focused approach, with a catalog of iPSC-derived neurons, neuroinflammatory cells, muscle cells, and cardiomyocytes manufactured at their ISO 9001:2015-accredited production facility.
axoCells cell types:
- cortical excitatory neurons
- striatal neurons
- cortical inhibitory interneurons
- sensory neurons
- motor neurons
- neuroinflammatory cells (microglia and astrocytes)
- cardiac cells (atrial and ventricular cardiomyocytes)
- muscle cells (skeletal myotubes)
Key therapy areas include:
- Alzheimer's disease
- Parkinson's disease
- ALS
- Huntington's disease
- Friedreich's ataxia
- Frontotemporal dementia
Axol Bioscience 2024 Catalog
The Axol Bioscience 2024 catalog showcases a comprehensive range of iPSC-derived cells and advanced in vitro systems, highlighting key therapy areas such as neuroscience, pain/inflammation, and cardiovascular applications.
Focus on Alzheimer's Disease
The Axol Bioscience "Focus on Alzheimer’s Disease" flyer details their innovative use of iPSC technology to create high-quality, functional cell types, such as cortical excitatory neurons, to advance research and drug development for Alzheimer's Disease.
Modeling ALS with iPSC-Derived Cells
The "Modeling ALS with iPSC-Derived Cells" flyer from Axol Bioscience outlines their cutting-edge approach to using iPSC technology to develop physiologically relevant motor neuron models, aimed at enhancing the understanding and treatment of Amyotrophic Lateral Sclerosis.
